ADENTRA (TSE:ADEN) PT Set at C$60.00 by Raymond James

ADENTRA (TSE:ADENGet Free Report) has been assigned a C$60.00 price objective by research analysts at Raymond James in a research report issued on Friday,BayStreet.CA reports. The firm currently has a “strong-buy” rating on the stock.

Several other brokerages have also recently commented on ADEN. National Bankshares lifted their price target on ADENTRA from C$57.00 to C$60.00 and gave the stock an “outperform” rating in a research note on Monday, October 7th. Acumen Capital decreased their target price on ADENTRA from C$56.00 to C$54.00 in a research report on Friday, November 15th. Finally, Stifel Nicolaus dropped their price target on ADENTRA from C$53.00 to C$50.00 and set a “buy” rating on the stock in a research report on Thursday, October 17th. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, ADENTRA presently has an average rating of “Buy” and an average target price of $55.14.

Check Out Our Latest Stock Analysis on ADEN

ADENTRA Trading Up 2.7 %

ADEN stock opened at $36.64 on Friday. The stock has a market cap of $916.73 million, a P/E ratio of 13.77 and a beta of 1.57. The company’s 50 day moving average is $39.51 and its two-hundred day moving average is $39.28. ADENTRA has a twelve month low of $29.81 and a twelve month high of $45.25.

About ADENTRA

(Get Free Report)

ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.

Featured Stories

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.